125 related articles for article (PubMed ID: 38048981)
1. Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability.
Ma B; Shi S; Ren S; Qu C; Zhao Z; An H
Eur J Pharmacol; 2024 Jan; 962():176240. PubMed ID: 38048981
[TBL] [Abstract][Full Text] [Related]
2. Human ether-à-go-go gene potassium channels are regulated by EGFR tyrosine kinase.
Wu W; Dong MQ; Wu XG; Sun HY; Tse HF; Lau CP; Li GR
Biochim Biophys Acta; 2012 Feb; 1823(2):282-9. PubMed ID: 22061963
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
Gessner G; Heinemann SH
Br J Pharmacol; 2003 Jan; 138(1):161-71. PubMed ID: 12522086
[TBL] [Abstract][Full Text] [Related]
4. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.
Menéndez ST; Villaronga MA; Rodrigo JP; Alvarez-Teijeiro S; García-Carracedo D; Urdinguio RG; Fraga MF; Pardo LA; Viloria CG; Suárez C; García-Pedrero JM
J Mol Med (Berl); 2012 Oct; 90(10):1173-84. PubMed ID: 22466864
[TBL] [Abstract][Full Text] [Related]
5. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry.
Hammadi M; Chopin V; Matifat F; Dhennin-Duthille I; Chasseraud M; Sevestre H; Ouadid-Ahidouch H
J Cell Physiol; 2012 Dec; 227(12):3837-46. PubMed ID: 22495877
[TBL] [Abstract][Full Text] [Related]
6. The voltage dependence of hEag currents is not determined solely by membrane-spanning domains.
Lörinczi E; Napp J; Contreras-Jurado C; Pardo LA; Stühmer W
Eur Biophys J; 2009 Mar; 38(3):279-84. PubMed ID: 18379771
[TBL] [Abstract][Full Text] [Related]
7. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin.
Schönherr R; Löber K; Heinemann SH
EMBO J; 2000 Jul; 19(13):3263-71. PubMed ID: 10880439
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for high-affinity block of human EAG potassium channels by antiarrhythmic agents.
Gessner G; Zacharias M; Bechstedt S; Schönherr R; Heinemann SH
Mol Pharmacol; 2004 May; 65(5):1120-9. PubMed ID: 15102940
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin Regulates Human Ether à Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain.
Lörinczi E; Helliwell M; Finch A; Stansfeld PJ; Davies NW; Mahaut-Smith M; Muskett FW; Mitcheson JS
J Biol Chem; 2016 Aug; 291(34):17907-18. PubMed ID: 27325704
[TBL] [Abstract][Full Text] [Related]
11. Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target.
Ma L; Chin YKY; Dekan Z; Herzig V; Chow CY; Heighway J; Lam SW; Guillemin GJ; Alewood PF; King GF
Biochem Pharmacol; 2018 Dec; 158():60-72. PubMed ID: 30149017
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
[TBL] [Abstract][Full Text] [Related]
13. Human EAG channels are directly modulated by PIP2 as revealed by electrophysiological and optical interference investigations.
Han B; He K; Cai C; Tang Y; Yang L; Heinemann SH; Hoshi T; Hou S
Sci Rep; 2016 Mar; 6():23417. PubMed ID: 27005320
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of potassium channel ether à go-go in human osteosarcoma.
Wu J; Wu X; Lian K; Lin B; Guo L; Ding Z
Neoplasma; 2012; 59(2):207-15. PubMed ID: 22248279
[TBL] [Abstract][Full Text] [Related]
15. Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B.
Sahoo N; Tröger J; Heinemann SH; Schönherr R
FEBS Lett; 2010 Sep; 584(18):3896-900. PubMed ID: 20708613
[TBL] [Abstract][Full Text] [Related]
16. Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities.
Boldrini-França J; Pinheiro-Junior EL; Peigneur S; Pucca MB; Cerni FA; Borges RJ; Costa TR; Carone SEI; Fontes MRM; Sampaio SV; Arantes EC; Tytgat J
Sci Rep; 2020 Mar; 10(1):4476. PubMed ID: 32161292
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of block of hEag1 K+ channels by imipramine and astemizole.
García-Ferreiro RE; Kerschensteiner D; Major F; Monje F; Stühmer W; Pardo LA
J Gen Physiol; 2004 Oct; 124(4):301-17. PubMed ID: 15365094
[TBL] [Abstract][Full Text] [Related]
18. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells.
Zhang YY; Yue J; Che H; Sun HY; Tse HF; Li GR
J Cell Physiol; 2014 Feb; 229(2):202-12. PubMed ID: 23881642
[TBL] [Abstract][Full Text] [Related]
19. The structural mechanism of KCNH-channel regulation by the eag domain.
Haitin Y; Carlson AE; Zagotta WN
Nature; 2013 Sep; 501(7467):444-8. PubMed ID: 23975098
[TBL] [Abstract][Full Text] [Related]
20. Functional distinction of human EAG1 and EAG2 potassium channels.
Schönherr R; Gessner G; Löber K; Heinemann SH
FEBS Lett; 2002 Mar; 514(2-3):204-8. PubMed ID: 11943152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
